Sankala Group’s Merck MRK Stock Holding History

Sankala Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.3K	Buy	231 +2	+0.9%	+$234	0.02%	297
2026 Q1	$27.7K	Hold	229	–	–	0.02%	288
2025 Q4	$28.4K	Buy	+229	New	+$21.5K	0.02%	281

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sankala Group's MRK Position: Q2 2026 in Review

Sankala Group increased its Merck (MRK) stake by 0.87% in Q2 2026, buying an estimated $234 and bringing the position to 231 shares worth $31.3K. The position accounts for 0.02% of the portfolio, ranked #297.

Sankala Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,851 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Sankala Group held 231 shares of Merck worth $31.3K as of Q2 2026.
Sankala Group bought 2 Merck shares in Q2 2026, an estimated $234.
Merck made up 0.02% of Sankala Group's portfolio in Q2 2026, its #297 holding.
Sankala Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,851 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.